LGT Fund Management Co Ltd. Acquires 5,747 Shares of Cardinal Health, Inc. $CAH

LGT Fund Management Co Ltd. increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 26.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,100 shares of the company’s stock after purchasing an additional 5,747 shares during the quarter. LGT Fund Management Co Ltd.’s holdings in Cardinal Health were worth $4,553,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health in the first quarter worth about $26,000. GW&K Investment Management LLC boosted its position in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after acquiring an additional 144 shares in the last quarter. NBC Securities Inc. bought a new stake in Cardinal Health during the 1st quarter valued at approximately $48,000. Zions Bancorporation National Association UT bought a new stake in Cardinal Health during the 1st quarter valued at approximately $52,000. Finally, Garde Capital Inc. bought a new stake in Cardinal Health during the 1st quarter valued at approximately $52,000. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on CAH. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Bank of America lifted their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, June 10th. Citigroup reaffirmed a “neutral” rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Argus set a $189.00 price objective on Cardinal Health in a research report on Friday, August 22nd. Finally, Robert W. Baird lifted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $165.93.

Cardinal Health Stock Down 2.5%

Shares of NYSE CAH opened at $154.50 on Friday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The firm has a market cap of $36.71 billion, a P/E ratio of 23.95, a PEG ratio of 1.34 and a beta of 0.71. The company has a 50 day moving average of $152.07 and a 200 day moving average of $150.25.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same period in the previous year, the business earned $1.84 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s payout ratio is presently 31.63%.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the sale, the chief executive officer directly owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.